CASE REPORT article
Front. Oncol.
Sec. Hematologic Malignancies
Isolated Acetabular Myeloid Sarcoma as the Initial Presentation of Extramedullary Blast Crisis in Chronic Myeloid Leukemia: A report of 2 cases and literature review
Cong Wang
Yuanyuan Nie
Qiuju Liu
Yan JIANG
Qiang Guo
Jing Bai
Shanshan Liu
Su Jun Gao
First Affiliated Hospital of Jilin University, Changchun, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
Background: Myeloid sarcoma (MS) as the initial manifestation of chronic myeloid leukemia (CML), while the bone marrow (BM) remains in the chronic phase, is exceedingly rare. Case presentation: We report two cases of MS initially presented with hip pain and soft tissue masses. Both patients had unremarkable complete blood counts and BM morphology, and initial core needle biopsies were misinterpreted as non-Hodgkin lymphoma. Further cytogenetic and molecular analyses, however, identified the Philadelphia chromosome, BCR::ABL rearrangement, and mutations in TP53, KMT2D and STAG2, establishing the diagnosis of MS secondary to CML in extramedullary blast phase. Both patients received tyrosine kinase inhibitors with or without chemotherapy, nevertheless, their disease progressed rapidly, resulting in death within one year. Conclusion: Through a comprehensive literature review, we identified 33 additional reported cases with the same diagnosis. This disease predominantly affects middle-aged men, with bone and parosteal soft tissues being the most common involved extramedullary site. Such patients may constitute a biologically distinct subgroup and, in some reports, have shown relatively favorable outcomes. However, our cases follow an aggressive clinical course, possibly influenced by high-risk molecular features. Large-scale clinical studies are required to clarify the biological heterogeneity of this subgroup and to optimize therapeutic strategies.
Summary
Keywords
Chronic myeloid leukemia, Extramedullary blast crisis, Gluteal mass, Imatinib, myeloid sarcoma
Received
20 November 2025
Accepted
16 February 2026
Copyright
© 2026 Wang, Nie, Liu, JIANG, Guo, Bai, Liu and Gao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Cong Wang
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.